Abstract
The aim of this research is to determine whether amikacin dosage guidelines for multi - drug resistant mycobacterial infections achieve peaks of 35 - 45 mg/L (OD) or 65 - 80 mg/L (TW) and troughs <5 mg/L.
Original language | English |
---|---|
Number of pages | 1 |
Publication status | Published - 11 May 2016 |
Event | Federation of Infection Societies/Healthcare Infection Society - Edinburgh International Conference Centre, Edinburgh, United Kingdom Duration: 5 Nov 2016 → 7 Nov 2016 |
Conference
Conference | Federation of Infection Societies/Healthcare Infection Society |
---|---|
Country/Territory | United Kingdom |
City | Edinburgh |
Period | 5/11/16 → 7/11/16 |
Keywords
- amikacin
- theraputic drug monitoring